Targeting the AKT/GSK3β/cyclin D1/Cdk4 survival signaling pathway for eradication of tumor radioresistance acquired by fractionated radiotherapy. (Q54604966)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Targeting the AKT/GSK3β/cyclin D1/Cdk4 survival signaling pathway for eradication of tumor radioresistance acquired by fractionated radiotherapy. |
scientific article |
Statements
Targeting the AKT/GSK3β/cyclin D1/Cdk4 survival signaling pathway for eradication of tumor radioresistance acquired by fractionated radiotherapy. (English)
Tsutomu Shimura
Satoshi Kakuda
Yasushi Ochiai
Yoshikazu Kuwahara
Yoshihiro Takai
Manabu Fukumoto
11 March 2011
80
2
540-548